Johnson & Johnson (NEO: JNJ)

Market Cap	499.91B
Revenue (ttm)	118.34B
Net Income (ttm)	19.81B
Shares Out	n/a
EPS (ttm)	8.15
PE Ratio	25.23
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,036
Open	19.14
Previous Close	19.09
Day's Range	19.10 - 19.31
52-Week Range	19.06 - 22.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 22, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lu...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 131,900
• Stock Exchange: Cboe Canada
• Ticker Symbol: JNJ

Financial Performance

In 2023, Johnson & Johnson's revenue was $85.16 billion, an increase of 6.46% compared to the previous year's $79.99 billion. Earnings were $35.15 billion, an increase of 95.94%.

Financial numbers in USD